Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults - A nationwide Registry-based study

Gudbjornsson B; Thorsteinsson SB; Sigvaldason H; Einarsdottir R; Johannsson M; Zoega H; Halldorsson M; Thorgeirsson G, 2010, 'Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults - A nationwide Registry-based study', European Journal of Clinical Pharmacology, vol. 66, pp. 619 - 625, 10.1007/s00228-010-0789-2

Opportunities (Scholarships, Grants and Research Positions)

3521284

Back to Top